Olduo Tablets 5/40 mg
Olmesartan Medoxomil 40mg · Amlodipine Maleate 6.42mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
MFDS item code 201405461 · Approved 2014.11.24
This product's status changed to Approval withdrawn on 2024.03.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or olmesartan medoxomil. It effectively lowers blood pressure and improves health by reducing the risk of cardiovascular complications.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be titrated using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The recommended doses are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg monotherapy. - 10/20 mg: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg monotherapy. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ∘Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild or moderate renal impairment (creatine clearance 20-60mL/min) is 20 mg once daily. Administration of this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild or moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. Patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics should be closely monitored for blood pressure and renal function. This medicine must not be administered to patients with severe hepatic impairment. (See Precautions for Use, 2. Patients Who Must Not Receive This Medicine.) ∘Elderly patients: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients.
∘Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to the active ingredient or similar substances, pregnant or breastfeeding women, patients with severe liver disease, aortic stenosis, biliary obstruction, those undergoing renal dialysis, patients in shock, or specific types of diabetic patients. Patients with hypotension who are deficient in fluid or salt may experience symptoms of low blood pressure upon initial dosing; close observation of their condition is necessary, and appropriate actions should be taken if hypotension occurs. Severe dilation of blood vessels can lead to hypotension, so caution is especially required for aortic stenosis patients during dosing. Patients with severe obstructive coronary artery disease may have an increased risk of angina or myocardial infarction after taking this medication, so it should be used with caution. The use of this medication is generally safe in patients with congestive heart failure, but care should be taken according to the condition. Patients with reduced kidney function should have regular tests, as this medication may impact kidney function. Patients with impaired liver function should also exercise caution while taking this medication. Common side effects may include dizziness, headache, hypotension, edema, nausea, rash, among others, and any abnormal symptoms should be discussed with healthcare professionals. During pregnancy, there is a special risk to the fetus; thus, anyone planning for pregnancy or who is pregnant must consult with a healthcare professional. Breastfeeding mothers should consider discontinuing breastfeeding or the medication due to its potential transfer into breast milk. The safety and effectiveness in pediatric patients under 18 years of age have not been established and are therefore not recommended. Elderly patients may have reduced kidney and liver function, so treatment should start at a low dose, and their condition should be closely observed. In case of overdose, low blood pressure and cardiac rhythm abnormalities may occur; if suspected, immediate medical evaluation is essential. Store the medication out of reach of children, and avoid direct sunlight and moisture during storage.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it is important to store it in a sealed container. Additionally, it should be kept at room temperature between 1°C and 30°C to maintain efficacy.
Pale yellow round film-coated tablets
28 tablets/((14 tablets/Alu-Alu)x2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 40mg · Amlodipine Maleate 6.42mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
Olmesartan Medoxomil 20mg · Amlodipine Maleate 6.42mg
Tablet · Prescription medication · Combination
Samchundang Pharm. Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.